SCHEMBL725033

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL725032	1.00	EGFR (0.86)	EGFRECE1MEN1MAPTKMT2A
	SCHEMBL723720	0.92	EGFR (1.00)	EGFRECE1MEN1MAPTKMT2A
	SCHEMBL723721	0.92	EGFR (1.00)	EGFRECE1MEN1MAPTKMT2A
	SCHEMBL12246870	0.88	EGFR (0.80)	EGFRECE1MEN1MAPTKMT2A
	SCHEMBL12337139	0.86	EGFR (0.65)	EGFRECE1MEN1MAPTKMT2A
	SCHEMBL786637	0.82	EGFR (0.60)	EGFRECE1MEN1MAPTKMT2A
	SCHEMBL786706	0.79	ALDH1A1 (0.57)	EGFRECE1ALDH1A1HDAC1HDAC8
	SCHEMBL804647	0.79	EGFR (0.55)	EGFRECE1MEN1MAPTKMT2A
	SCHEMBL722468	0.78	EGFR (0.76)	EGFRECE1MEN1MAPTKMT2A
	SCHEMBL724051	0.78	EGFR (0.76)	EGFRECE1MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.